Thymosilib (Thymomax)
Product detail for Thymosilib, INN: thymosilib. Therapeutic area: Immunology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-017
INN
thymosilib
Therapeutic Area
Immunology
Status
In Progress
Owner
Tomoko Ikeda
Created
2022-03-24
Last Updated
2024-05-11
Markets
11
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 100 mg/mL | Oral |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-022 | Sacubitrivex | sacubitrivex | 54693-87-2 | small-molecule | Active |
| SUB-039 | Trehalose | trehalose | 96446-61-5 | small-molecule | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| SFDA-2023-0017 | Singapore | sMAA | Failed | Carlos Mendez | 2022-11-21 |
| TGA-2023-0047 | Singapore | NDA | Completed | Sarah Chen | 2024-01-16 |
| SFDA-2023-0077 | Singapore | BLA | Completed | Nadia Petrova | 2023-04-15 |
Markets (11)